RAMAT GAN, Israel, Nov. 6, 2018 /PRNewswire/ — Subsequent to its recent announcement of the successful tests of its innovative delivery formulation aimed at Multiple Myeloma therapy, OWC Pharmaceutical Research Corp. (OTCQB: OWCP), a developer of cannabinoid-based therapies targeting a variety of different medical conditions and disorders, announced today that the company’s management will be attending the 2018 MJBizCon (Marijuana Business Conference), to be held at Las Vegas Convention Center, on November 14-16, 2018.
MJBizDaily’s flagship event, MJBizCon, is the preeminent conference to drive business deals and forge valuable connections for cannabis professionals in business today. Members of OWCPs management team will take part, along with an estimated 20,000+ cannabis professionals and 1,000+ exhibitors in this world leading event.
During MJBizCon the company’s management will hold meetings with investors, researchers and business partners as part
... read more at: https://www.prnewswire.com/news-releases/owc-pharmaceutical-research-corp-to-meet-with-investors-researchers-and-business-partners-at-2018-mjbizcon-revealing-the-testing-of-novel-formulation-for-multiple-myeloma-therapy-300744688.html